#394 ‒ Sleep pharmacology: the role of medications in healthy sleep, the promise of emerging therapies, and the evidence for common sleep supplements

The most dangerous sleep medication isn't a drug at all—it's the assumption that all sleep problems are the same. In this deep dive, Peter Attia dismantles the myth of one-size-fits-all sleep solutions, revealing that insomnia isn't a broken system but a mismatch between modern life and our ancient biology. He argues that the real crisis isn't sleep deprivation, but sleep architecture collapse—where medications like benzodiazepines and Z-drugs flatten brain activity, suppress deep slow-wave sleep, and impair the brain's ability to clear toxins like beta-amyloid. The breakthrough comes with dual orexin receptor antagonists (DORAs), which don't force sleep but allow natural sleep processes to emerge by gently dialing down the brain's wakefulness system. Early evidence suggests DORAs may actually protect against Alzheimer’s by enhancing glymphatic clearance during deep sleep—a mechanism that traditional sleep aids like Ambien fail to replicate. Yet even DORAs come with risks: narcolepsy-like side effects, residual daytime sedation, and gender-specific differences in efficacy. Meanwhile, melatonin isn't a sedative but a circadian signal, and its overuse in high doses can disrupt timing rather than fix it. The episode ends with a stark warning: the cheapest, most accessible sleep aids—antihistamines like Benadryl—carry long-term neurological risks that may accelerate dementia, ironically undermining the very health they promise to protect.